Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Japan Institute of Pharmaco-Vigilance (JIP) is an independent non-profit organization based in Osaka, Japan, dedicated to drug safety and pharmacovigilance. Established to provide unbiased information on medicines, the institute operates without funding from the pharmaceutical industry to maintain its objectivity and scientific integrity. JIP is best known for publishing "Kusuri-no-Check" (The Drug Monitor), a periodical that evaluates the efficacy and safety of drugs for both healthcare professionals and the general public. The organization actively engages in research, analyzing clinical trial data and post-marketing reports to identify potential risks that may be overlooked by regulatory bodies. JIP is a member of the International Society of Drug Bulletins (ISDB) and plays a significant role in health advocacy and drug policy critique in Japan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Institute of Pharmaco-Vigilance.